• Users Online: 263
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2020  |  Volume : 20  |  Issue : 2  |  Page : 120-125

Comparing high-dose and low-dose intravenous iron therapy in hemodialysis patients in Benha city, Egypt

1 Department of Internal Medicine, Faculty of Medicine, Benha University, Benha, Egypt
2 Internal Medicine Department Dialysis Unit, Benha Teaching Hospital, Benha, Egypt

Correspondence Address:
Prof. Ahmed E Mansour
Lecturer of Internal Medicine and Nephrology, MD Internal Medicine, Postal 11311
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jesnt.jesnt_38_19

Rights and Permissions

Background Since the introduction of erythropoiesis-stimulating agents for the management of anemia in patients with chronic kidney disease (CKD), intravenous (i.v.) iron has been universally used, especially with hemodialysis (HD) patients, as their average daily losses of iron typically exceed the oral absorption of iron. The maintenance i.v. iron regimens vary widely between countries and even among HD centers of the same country. Aim The aim of this study was to find out if high-dose i.v. iron will be superior to low-dose i.v. iron for treating anemia in HD patients. Patients and methods This study was carried out at HD units of Benha University Hospitals and Benha Teaching Hospital from March 2019 till September 2019. It was carried out on 100 patients with CKD stage V on HD, who were subdivided into two groups. Group Ι: 50 patients with CKD stage V on HD who were eligible for low-dose i.v. iron therapy. Group П: 50 patients with CKD stage V on HD who were eligible for high-dose i.v. iron therapy. Results There was an improvement of hemoglobin, serum ferritin, and transferrin saturation after treatment with low-dose and high-dose iron therapy. However, the high-dose iron therapy was associated with a high statistically significant improvement compared with low-dose iron therapy. Conclusion High-dose i.v. iron was superior to low-dose i.v. iron for treating anemia in HD patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded106    
    Comments [Add]    

Recommend this journal